Touchstone Mid Cap Growth Fund Class R6 (TFGRX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
38.94
-0.07 (-0.18%)
Mar 7, 2025, 5:00 PM EST
-1.64% (1Y)
Fund Assets | 1.04B |
Expense Ratio | 0.78% |
Min. Investment | $50,000 |
Turnover | n/a |
Dividend (ttm) | 1.13 |
Dividend Yield | 3.04% |
Dividend Growth | n/a |
Payout Frequency | n/a |
Ex-Dividend Date | Dec 11, 2024 |
Previous Close | 39.01 |
YTD Return | -6.60% |
1-Year Return | 0.87% |
5-Year Return | 65.92% |
52-Week Low | n/a |
52-Week High | n/a |
Beta (5Y) | n/a |
Holdings | 59 |
Inception Date | Feb 10, 2020 |
About TFGRX
The Touchstone Mid Cap Growth Fund Class R6 (TFGRX) seeks to increase the value of Fund shares as a primary goal and to earn income as a secondary goal. Under normal circumstances, the Fund will invest at least 80% of its assets in common stocks of mid cap U.S. companies.
Category Mid-Cap Growth
Performance Rating Above Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol TFGRX
Share Class Class R6
Index Russell MidCap Growth TR
Performance
TFGRX had a total return of 0.87% in the past year. Since the fund's inception, the average annual return has been 7.08%, including dividends.
Top 10 Holdings
29.74% of assetsName | Symbol | Weight |
---|---|---|
Axon Enterprise, Inc. | AXON | 4.48% |
Palantir Technologies Inc. | PLTR | 3.56% |
Vertiv Holdings Co | VRT | 3.46% |
TransDigm Group Incorporated | TDG | 3.23% |
AppLovin Corporation | APP | 2.89% |
HubSpot, Inc. | HUBS | 2.72% |
Ascendis Pharma A/S | ASND | 2.71% |
Atlassian Corporation | TEAM | 2.44% |
Ares Management Corporation | ARES | 2.16% |
DexCom, Inc. | DXCM | 2.09% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 11, 2024 | $1.12607 | Dec 11, 2024 |
Dec 9, 2022 | $0.72706 | Dec 12, 2022 |
Dec 9, 2021 | $6.37391 | Dec 10, 2021 |
Dec 10, 2020 | $2.53862 | Dec 11, 2020 |